We are live on
!
Find out more
KCM
Kornitzer Capital Management Portfolio holdings
AUM
$4.79B
1-Year Est. Return
30.56%
This Fund
S&P 500
This Quarter
Est. Return
+10.76%
1 Year Est. Return
+30.56%
3 Year Est. Return
+78.14%
5 Year Est. Return
+100.44%
10 Year Est. Return
+507.87%
AUM
$4.94B
AUM Growth
+$275M
(+5.9%)
Cap. Flow
-$134M
Cap. Flow
% of AUM
-2.72%
Top 10 Holdings %
Top 10 Hldgs %
16.92%
Holding
527
New
22
Increased
110
Reduced
192
Closed
28
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
FIVE9
FIVN
|
+$9.95M |
| 2 |
OmniAb
OABI
|
+$9.24M |
| 3 |
Clearfield
CLFD
|
+$7.38M |
| 4 |
Monolithic Power Systems
MPWR
|
+$7.32M |
| 5 |
SiTime
SITM
|
+$7.29M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$18.9M |
| 2 |
Varonis Systems
VRNS
|
+$16.5M |
| 3 |
Calix
CALX
|
+$13.8M |
| 4 |
HealthEquity
HQY
|
+$9.71M |
| 5 |
Ametek
AME
|
+$7.61M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.04% |
| 2 | Healthcare | 18.33% |
| 3 | Energy | 13.38% |
| 4 | Consumer Staples | 11.65% |
| 5 | Industrials | 11.2% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
501
Zillow
Z
$7.67B
| – | – |
-37,000
| Closed | -$1.06M |
|
|
CTLT
502
DELISTED
CATALENT, INC.
CTLT
| – | – |
-64,196
| Closed | -$4.64M |
|
|
LTHM
503
DELISTED
Livent Corporation
LTHM
| – | – |
-8,508
| Closed | -$261K |
|
|
SYNH
504
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| – | – |
-71,770
| Closed | -$3.38M |
|
|
SI
505
DELISTED
Silvergate Capital Corporation
SI
| – | – |
-39,845
| Closed | -$3M |
|
|
ABMD
506
DELISTED
Abiomed Inc
ABMD
| – | – |
-6,700
| Closed | -$1.65M |
|
Similar funds
MP
AC
RC
JCM
SAMU
BMO
VDI
Kornitzer Capital Management's Q4 2022 Portfolio in Review
As of Q4 2022, Kornitzer Capital Management held 527 positions worth $4.94B, up 5.9% from $4.66B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Kornitzer Capital Management's Q4 2022 filing shows 22 new, 110 increased, 192 reduced and 28 closed positions. Its largest new stake was FIVE9: 158,520 shares worth $10.8M. The largest sale was Horizon Therapeutics Public Limited Company Ordinary Shares, an estimated $18.9M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 21% a quarter earlier, followed by Healthcare and Energy.
- Kornitzer Capital Management's largest Q4 2022 buy was FIVE9: 158,520 shares worth $10.8M.
- Kornitzer Capital Management added most to Bio-Rad Laboratories Class A in Q4 2022, an estimated $6.56M increase.
- Kornitzer Capital Management's biggest Q4 2022 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $18.9M.
- Kornitzer Capital Management fully exited First Advantage in Q4 2022, selling an estimated $6.24M.
- Kornitzer Capital Management's ten largest holdings make up 17% of its $4.94B portfolio in Q4 2022.
- Kornitzer Capital Management opened 22 new positions and closed 28 in Q4 2022.
- Kornitzer Capital Management's portfolio value rose 5.9% quarter-over-quarter to $4.94B.
Based on Kornitzer Capital Management's 13F filing for Q4 2022, filed 2 Feb 2023.